Israeli-Filipino joint venture Savepoint Biotek has been approved as manufacturer of oral COVID-19 vaccines with projected annual sales of $180 million from the Philippines and export markets. The Philippine Economic Zone Authority (PEZA) Board has approved Savepoint Biotek's registration agreement
Total medical product manufacturing investments in the country’s economic zones have reached P21.8 billion, but robust growth is expected following keen interest from world’s pharmaceutical companies, including Pakistanis, to expand operations in the Philippines.
peza web
In a virtual brie